Neurotrope Inc. | |
Stock Exchange | Other OTC |
EPS |
$1.48 |
Market Cap |
$96.84 M |
Shares Outstanding |
12.92 M |
Public Float |
4.99 M |
Address |
205 East 42nd Street New York New York 10017 United States |
Employees | - |
Website | http://www.neurotropebioscience.com |
Updated | 07/08/2019 |
Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. It operates through the following geographical segments: US; European Union; Japan; and China and India. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. |